Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif

Abstract

The adapter Grb2 is an important mediator of normal cell proliferation and oncogenic signal transduction events. It consists of a central SH2 domain flanked by two SH3 domains. While the binding specificities of the Grb2 SH2 and N-terminal SH3 domain [Grb2 SH3(N)] have been studied in detail, binding properties of the Grb2 SH3(C) domain remained poorly defined. Gab1, a receptor tyrosine kinase substrate which associates with Grb2 and the c-Met receptor, was previously shown to bind Grb2 via a region which lacks a Grb2 SH3(N)-typical motif (P-x-x-P-x-R). Precipitation experiments with the domains of Grb2 show now that Gab1 can bind stably to the Grb2 SH3(C) domain. For further analyses, Gab1 mutants were generated by PCR to test in vivo residues thought to be crucial for Grb2 SH3(C) binding. The Grb2 SH3(C) binding region of Gab1 has significant homology to a region of the adapter protein SLP-76. Peptides corresponding to epitopes SLP-76, Gab1, SoS and other proteins with related sequences, as well as mutant peptides were synthesized and analysed by tryptophan-fluorescence spectrometry and by in vitro competition experiments. These experiments define a 13 amino acid sequence with the unusual consensus motif P-x-x-x-R-x-x-K-P as required for a stable binding to the SH3(C) domain of Grb2. Additional analyses point to a distinct binding specificity of the Grb2-homologous adapter protein Mona (Gads), indicating that the proteins of the Grb2 adapter family may have partially overlapping, yet distinct protein binding properties.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Asada H, Ishii N, Sasaki Y, Endo K, Kasai H, Tanaka N, Takeshita T, Tsuchiya S, Konno T and Sugamura K. . 1999 J. Exp. Med. 189: 1383–1390.

  • Bourette RP, Arnaud S, Myles GM, Blanchet JP, Rohrschneider LR and Mouchiroud G. . 1998 EMBO J. 17: 7273–7281.

  • Bowtell D, Fu P, Simon M and Senior P. . 1992 Proc. Natl. Acad. Sci. USA 89: 6511–6515.

  • Brugge JS. . 1993 Science 260: 918–919.

  • Buday L and Downward J. . 1993 Cell 73: 611–620.

  • Buday L. . 1999 Biochim. Biophys. Acta 1422: 187–204.

  • Carlier MF, Nioche P, Broutin-L'Hermite I, Boujemaa R, Le Clainche C, Egile C, Garbay C, Ducruix A, Sansonetti P and Pantaloni D. . 2000 J. Biol. Chem. 275: 21946–21952.

  • Chardin P, Camonis JH, Gale NW, van Aelst L, Schlessinger J, Wigler MH and Bar-Sagi D. . 1993 Science 260: 1338–1343.

  • Chardin P, Cussac D, Maignan S and Ducruix A. . 1995 FEBS Lett. 369: 47–51.

  • Cheng AM, Saxton TM, Sakai R, Kulkarni S, Mbamalu G, Vogel W, Tortorice CG, Cardiff RD, Cross JC, Muller WJ and Pawson T. . 1998 Cell 95: 793–803.

  • Chien CT, Bartel PL, Sternglanz R and Fields S. . 1991 Proc. Natl. Acad. Sci. USA 88: 9578–9582.

  • Clark SG, Stern MJ and Horvitz HR. . 1992 Nature 356: 340–344.

  • Clements JL, Boerth NJ, Lee JR and Koretzky GA. . 1999 Annu. Rev. Immunol. 17: 89–108.

  • Cowburn D, Zheng J, Xu Q and Barany G. . 1995 J. Biol. Chem. 270: 26738–26741.

  • Cussac D, Vidal M, Leprince C, Liu WQ, Cornille F, Tiraboschi G, Roques BP and Garbay C. . 1999 FASEB J. 13: 31–38.

  • den Hertog J and Hunter T. . 1996 EMBO J. 15: 3016–3027.

  • Donovan JA, Wange RL, Langdon WY and Samelson LE. . 1994 J. Biol. Chem. 269: 22921–22924.

  • Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM and Weinberg RA. . 1993 Nature 363: 45–51.

  • Eijkelenboom AP, Lutzke RA, Boelens R, Plasterk RH, Kaptein R and Hard K. . 1995 Nat. Struct. Biol. 2: 807–810.

  • Ellis JH, Ashman C, Burden MN, Kilpatrick KE, Morse MA and Hamblin PA. . 2000 J. Immunol. 164: 5805–5814.

  • Feller SM, Knudsen B and Hanafusa H. . 1995a Oncogene 10: 1465–1473.

  • Feller SM, Knudsen B, Wong TW and Hanafusa H. . 1995b Meth. Enzymol. 255: 369–378.

  • Feng GS, Ouyang YB, Hu DP, Shi ZQ, Gentz R.and Ni J. . 1996 J. Biol. Chem. 271: 12129–12132.

  • Fixman ED, Holgado-Madruga M, Nguyen L, Kamikura DM, Fournier TM, Wong AJ and Park M. . 1997 J. Biol. Chem. 272: 20167–20172.

  • Fu S, Waha A and Vogt PK. . 2000 Oncogene 19: 3537–3545.

  • Fukazawa T, Reedquist KA, Trub T, Soltoff S, Panchamoorthy G, Druker B, Cantley L, Shoelson SE and Band H. . 1995 J. Biol. Chem. 270: 19141–19150.

  • Gale NW, Kaplan S, Lowenstein EJ, Schlessinger J and Bar-Sagi D. . 1993 Nature 363: 88–92.

  • Gorina S and Pavletich NP. . 1996 Science 274: 1001–1005.

  • Goudreau N, Cornille F, Duchesne M, Parker F, Tocque B, Garbay C and Roques BP. . 1994 Nat. Struct. Biol. 1: 898–907.

  • Hildt E and Oess S. . 1999 J. Exp. Med. 189: 1707–1714.

  • Holgado-Madruga M, Emlet DR, Moscatello DK, Godwin AK and Wong AJ. . 1996 Nature 379: 560–564.

  • Jackman JK, Motto DG, Sun Q, Tanemoto M, Turck CW, Peltz GA, Koretzky GA and Findell PR. . 1995 J. Biol. Chem. 270: 7029–7032.

  • Kang H, Freund C, Duke-Cohan JS, Musacchio A, Wagner G and Rudd CE. . 2000 EMBO J. 19: 2889–2899.

  • Kardinal C, Konkol B, Schulz A, Posern G, Lin H, Adermann K, Eulitz M, Estrov Z, Talpaz M, Arlinghaus RB and Feller SM. . 2000 FASEB J. 14: 1529–1538.

  • Kiess M, Scharm B, Aguzzi A, Hajnal A, Klemenz R, Schwarte-Waldhoff I and Schafer R. . 1995 Oncogene 10: 61–68.

  • Kim HH, Tharayil M and Rudd CE. . 1998 J. Biol. Chem. 273: 296–301.

  • Kishan RKV, Scita G, Wong WT, Di Fiori PP and Newcomer ME. . (1997) Nature Struct. Biol. 4: 739–743.

  • Knudsen BS, Zheng J, Feller SM, Mayer JP, Burrell SK, Cowburn D and Hanafusa H. . 1995 EMBO J. 14: 2191–2198.

  • Kohda D, Terasawa H, Ichikawa S, Ogura K, Hatanaka H, Mandiyan V, Ullrich A, Schlessinger J and Inagaki F. . 1994 Structure 2: 1029–1040.

  • Law CL, Ewings MK, Chaudhary PM, Solow SA, Yun TJ, Marshall AJ, Hood L and Clark EA. . 1999 J. Exp. Med. 189: 1243–1253.

  • Li N, Batzer A, Daly R, Yajnik V, Skolnik E, Chardin P, Bar-Sagi D, Margolis B and Schlessinger J. . 1993 Nature 363: 85–88.

  • Liu SK and McGlade CJ. . 1998 Oncogene 17: 3073–3082.

  • Liu SK, Fang N, Koretzky GA and McGlade CJ. . 1999 Curr. Biol. 9: 67–75.

  • Liu SK, Smith CA, Arnold R, Kiefer F and McGlade CJ. . 2000 J. Immunol. 165: 1417–1426.

  • Lock LS, Royal I, Naujokas MA and Park M. . (2000) J. Biol. Chem. 275: 31536–31545.

  • Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, Ullrich A, Skolnik EY, Bar-Sagi D and Schlessinger J. . 1992 Cell 70: 431–442.

  • Lupher Jr ML, Rao N, Eck MJ and Band H. . 1999 Immunol. Today 20: 375–382.

  • Mongiovi AM, Romano PR, Panni S, Mendoza M, Wong WT, Musacchio A, Cesareni G and Di Fiore PP. . 1999 EMBO J. 18: 5300–5309.

  • Motto DG, Ross SE, Wu J, Hendricks-Taylor LR and Koretzky GA. . 1996 J. Exp. Med. 183: 1937–1943.

  • Nguyen JT, Turck CW, Cohen FE, Zuckermann RN and Lim WA. . 1998 Science 282: 2088–2092.

  • Nguyen JT, Porter M, Amoui M, Miller WT, Zuckermann RN and Lim WA. . 2000 Chem. Biol. 7: 463–473.

  • Odai H, Sasaki K, Iwamatsu A, Hanazono Y, Tanaka T, Mitani K, Yazaki Y and Hirai H. . 1995 J. Biol. Chem. 270: 10800–10805.

  • Oehrl W, Kardinal C, Ruf S, Adermann K, Groffen J, Feng GS, Blenis J, Tan TH and Feller SM. . 1998 Oncogene 17: 1893–1901.

  • Okkenhaug K and Rottapel R. . 1998 J. Biol. Chem. 273: 21194–21202.

  • Park H, Wahl MI, Afar DE, Turck CW, Rawlings DJ, Tam C, Scharenberg AM, Kinet JP and Witte ON. . 1996 Immunity 4: 515–525.

  • Park RK, Kyono WT, Liu Y and Durden DL. . 1998 J. Immunol. 160: 5018–5027.

  • Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J and Gishizky ML. . 1993 Cell 75: 175–185.

  • Pomerance M, Multon MC, Parker F, Venot C, Blondeau JP, Tocque B and Schweighoffer F. . 1998 J. Biol. Chem. 273: 24301–24304.

  • Posern G, Zheng J, Knudsen BS, Kardinal C, Muller KB, Voss J, Shishido T, Cowburn D, Cheng G, Wang B, Kruh GD, Burrell SK, Jacobson CA, Lenz DM, Zamborelli TJ, Adermann K, Hanafusa H and Feller SM. . 1998 Oncogene 16: 1903–1912.

  • Qiu M, Hua S, Agrawal M, Li G, Cai J, Chan E, Zhou H, Luo Y and Liu M. . 1998 Biochem. Biophys. Res. Commun. 253: 443–447.

  • Reuther GW and Der CJ. . 2000 Curr. Opin. Cell. Biol. 12: 157–165.

  • Robinson MJ and Cobb MH. . 1997 Curr. Opin. Cell. Biol. 9: 180–186.

  • Rozakis-Adcock M, McGlade J, Mbamalu G, Pelicci G, Daly R, Li W, Batzer A, Thomas S, Brugge J, Pelicci PG et al. 1992 Nature 360: 689–692.

  • Rozakis-Adcock M, Fernley R, Wade J, Pawson T and Bowtell D. . 1993 Nature 363: 83–85.

  • Schaeper U, Gehring NH, Fuchs KP, Sachs M, Kempkes B and Birchmeier W. . 2000 J. Cell. Biol. 149: 1419–1432.

  • Simon MA, Dodson GS and Rubin GM. . 1993 Cell 73: 169–177.

  • Sparks AB, Rider JE, Hoffman NG, Fowlkes DM, Quillam LA and Kay BK. . 1996 Proc. Natl. Acad. Sci. USA 93: 1540–1544.

  • Takenawa T, Miki H and Matuoka K. . 1998 Curr. Top. Microbiol. Immunol. 228: 325–342.

  • Tanaka N, Kaneko K, Asao H, Kasai H, Endo Y, Fujita T, Takeshita T and Sugamura K. . 1999 J. Biol. Chem. 274: 19129–19135.

  • Terasawa H, Kohda D, Hatanaka H, Tsuchiya S, Ogura K, Nagata K, Ishii S, Mandiyan V, Ullrich A, Schlessinger J et al. 1994 Nat. Struct. Biol. 1: 891–897.

  • Trenkle T, McClelland M, Adlkofer K and Welsh J. . 2000 Gene 245: 139–149.

  • Whisstock JC and Lesk AM. . 1999 Trends Biochem. Sci. 24: 132–133.

  • Xu XX, Yi T, Tang B and Lambeth JD. . 1998 Oncogene 16: 1561–1569.

Download references

Acknowledgements

We wish to thank Guy Mouchiroud and Roland Bourette for helpful discussions. The support of the Wilhelm-Sander-Stiftung and the Deutsche Forschungsgemeinschaft is gratefully acknowledged.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lewitzky, M., Kardinal, C., Gehring, N. et al. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif. Oncogene 20, 1052–1062 (2001). https://doi.org/10.1038/sj.onc.1204202

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204202

Keywords

This article is cited by

Search

Quick links